Aitrium
RadiopharmaceuticalsOncology RTQATeamBlogContact
Talk to Aitrium
For sponsors, CROs and core labs

Trial readiness starts with evidence.

Specialist delivery for radiopharmaceutical machine readiness and radiotherapy quality assurance in oncology trials.

Discuss your trial ↗
Clinical sitesEvidence recordTrial-ready evidence
Radiopharmaceutical readinessStart-up & ReadySet↘External Beam RTQA for oncology trialsData collection to central review↘
Our oncology trial partners

Experience in collaborative cancer research.

EORTCTROGZAS
Radiopharmaceutical Readiness

Move calibration evidence off the critical path.

Start-up brings specialist oversight and faster timelines to site credentialing. ReadySet allows you to reuse existing calibration evidence.

One clear handoff: documented coverage, reviewed results and resolved findings for your sponsor or core lab to assess.

Explore RPT readiness →
Start-up →ReadySet →
Site credentialingLu-177 / SPECT
Lu-177 SPECTCollection · Review · Reuse

Begin alongside approvals.

Network credentialing can begin before or alongside study IRB, CTRA and budget approvals, subject to site authorization and agreed resources.

Check the evidence on site.

Personnel and software check collection against the agreed manual, so gaps can be addressed before handoff.

Carry the evidence forward.

Match current records to the next trial’s requirements before requesting more camera time or repeat site work.

Site access and agreed scope govern scheduling. Evidence reuse depends on current coverage and agreed rights; the sponsor or core lab retains trial-specific acceptance.

External Beam RTQA for oncology trials

A clear view of RT quality.

Bring treatment data collection, protocol checks and central review into one workflow. Give trial teams a consistent way to track submissions and review radiation planning quality.

Explore oncology RTQA →
Product workflow →Security →
Aitrium central review workspace showing treatment images, contours and dose information
The Aitrium central review workspace.
98 secondsMedian submission time, including user review
10 institutionsClinical institutions in the measured cohort
6 countriesRepresented in production submissions

RTQA platform audit telemetry: 54 production submissions, March to July 2026. Median active processing: 41 seconds. These figures describe the measured RTQA workflow, not RPT credentialing timelines.

Let’s start with your trial.

Bring your requirements and site list. We’ll help define the evidence, the delivery scope and the route to review.

Discuss your trial →
Aitrium
Aitrium
RadiopharmaceuticalsOncology RTQATeamBlogContactPrivacyTerms
aitriumos.com · © 2026 Aitrium